Migraine

A migraine is a severe headache causing pain in the front or side of the head. In the UK, migraines affect about 15% of the population and the headaches are three times more common among women than men. Migraines usually first start in young adulthood but it is possible for the headaches to start later in life.
What are Migraines?

Migraine is a severe form of headache felt as a throbbing pain at the front or side of the head. Migraines may also be accompanied by other symptoms such as a sensitivity to light or nausea.

Read More

Overview

Feature Articles

Latest Migraine News and Research

Telemedicine use in neurology affected by race and neighborhood disparities

Telemedicine use in neurology affected by race and neighborhood disparities

High blood pressure, atrial fibrillation and smoking linked to severe stroke risk

High blood pressure, atrial fibrillation and smoking linked to severe stroke risk

Daytime sleepiness and low enthusiasm may be linked to motoric cognitive risk syndrome

Daytime sleepiness and low enthusiasm may be linked to motoric cognitive risk syndrome

Healthy habits in middle age may protect against neurological conditions

Healthy habits in middle age may protect against neurological conditions

Poor sleep quality linked to increased brain aging in middle age

Poor sleep quality linked to increased brain aging in middle age

Migraines linked to healthy vascular system despite cardiovascular risk factors

Migraines linked to healthy vascular system despite cardiovascular risk factors

Mental health problems lead to greater productivity loss than other chronic conditions

Mental health problems lead to greater productivity loss than other chronic conditions

Clot-busting drug tenecteplase shows promising results for stroke recovery

Clot-busting drug tenecteplase shows promising results for stroke recovery

Simple dietary changes may help reduce migraine severity and medication use

Simple dietary changes may help reduce migraine severity and medication use

New magnetogenetics technology holds promise as a powerful tool for studying the brain

New magnetogenetics technology holds promise as a powerful tool for studying the brain

Research shows link between multiple sclerosis to increased risk of certain cancers

Research shows link between multiple sclerosis to increased risk of certain cancers

Study reveals widespread long-COVID symptoms, challenging WHO definition

Study reveals widespread long-COVID symptoms, challenging WHO definition

Research highlights negative brain health outcomes among LGBTQ+ individuals

Research highlights negative brain health outcomes among LGBTQ+ individuals

Research questions effectiveness of MS medications in slowing disability progression

Research questions effectiveness of MS medications in slowing disability progression

Triptans better at relieving migraine pain than recently marketed and more expensive drugs

Triptans better at relieving migraine pain than recently marketed and more expensive drugs

Triptans prove to be more effective for acute migraines than newer drugs

Triptans prove to be more effective for acute migraines than newer drugs

MIND diet may reduce cognitive decline risk, study suggests

MIND diet may reduce cognitive decline risk, study suggests

New meta-analysis links dizziness in older adults to increased fall risk

New meta-analysis links dizziness in older adults to increased fall risk

Study links diabetes drugs to lower risk of dementia and Parkinson's disease

Study links diabetes drugs to lower risk of dementia and Parkinson's disease

Mount Sinai researchers uncover genetic basis of fibromuscular dysplasia

Mount Sinai researchers uncover genetic basis of fibromuscular dysplasia

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.